Fiscal Year Ending March 2027 Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)

Summary of Results

For this interim period, consolidated results showed net sales of 26,893 hundred million yen, up 18.5% from the same period last year; operating income of 3,990 hundred million yen; ordinary income of 4,577 hundred million yen; and net income attributable to owners of parent of 3,392 hundred million yen, representing significant profit growth. The market environment benefited from strength in the medical device and semiconductor-related markets. Although segment information is not disclosed, solid demand for the core magnet pump products drove results. Total assets stood at 60,374 hundred million yen and the equity ratio was 74.0%, demonstrating a stable financial base. A dividend of 35 yen (ordinary) plus a 10 yen commemorative dividend will be paid at the end of the second quarter, and the full-year forecast remains unchanged.

Outlook and Impact for Investors

Under the Medium-Term Management Plan 2027, the company will continue domestic solution-based sales and expansion into overseas markets. While uncertainties remain including foreign exchange effects and raw material price trends, the company is strengthening the foundations that support growth. Although full-year earnings forecasts are unchanged, steady performance based on interim results is expected for both sales and profits, and investors may focus on the company's financial soundness and stable dividend policy.